| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |